Join to access to all OVN content. Join for Free
Why MSLs Need a Personal Board of Directors
Medical Science Liaisons personal board of directors MSL career development mentorship in medical affairs Medical Affairs Executive Coach

Why MSLs Need a Personal Board of Directors


Share This Article


Summary

In this episode, Tom Caravela welcomes Marieke Jonkman to discuss the concept of creating a personal board of directors for Medical Science Liaisons (MSLs). Marieke shares her career journey and emphasizes the importance of selecting and approaching the right individuals to form a supportive board. The conversation covers the roles and expectations of board members in an MSL's development, highlighting the reciprocal nature of mentorship and the involvement of managers. Marieke also provides insights on maintaining and nurturing these crucial relationships. The episode concludes with closing remarks and a call to action for listeners to engage with the MSL Talk community.

My guest today is Marieke Jonkman, Medical Affairs Executive Coach at the Medical Affairs Institute and we discuss why MSLs should have their own personal board of directors

Marieke discusses…

πŸ‘‰ What would a personal board of directors look like
πŸ‘‰ How to go about finding people for your PBD
πŸ‘‰ Who you should ask to be on your board
πŸ‘‰ How to approach a potential board member

Click for Source
Medical Science Liaisons, personal board of directors, MSL career development, mentorship in medical affairs, Medical Affairs Executive Coach

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, GaΓ«lle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN